Human immunodeficiency virus type 1 RNA polymerase chain reaction reasonably excludes infection in exposed infants

Pediatric Infectious Disease Journal

Volumn 22, Issue 1, 2003, Pages 97-99

  Luján Zilbermann, Jorge ^a   Bitar, Wally ^a   Knapp, Katherine ^a   Flynn, Patricia ^a  

^a NONE

Author keywords

Human immunodeficiency virus; Human immunodeficiency virus type 1 RNA polymerase chain reaction; Nucleic acid sequence based amplification assay; Perinatal human immunodeficiency virus infection

Indexed keywords

VIRUS RNA;

ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INFANT; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PERINATAL INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; VALIDATION PROCESS; VERTICAL TRANSMISSION;

EID: 0037231582     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200301000-00027     Document Type: Article

References (14)

1. Mofenson LM, and the Committee on Pediatric AIDS. Technical report: perinatal human immunodeficiency virus testing and prevention of transmission. Pediatrics 2000;106:E88.
2. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study. N Engl J Med 1994;331:1173-80.
3. Centers for Disease Control and Prevention. Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus and acquired immunodeficiency syndrome. MMWR 1999;48(RR-13):1-36.
4. Centers for Disease Control and Prevention. Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR 1998;47(RR-4):1-38.
5. Rogers MF, Ou CY, Rayfield M, et al. Use of the polymerase chain reaction for early detection of the proviral sequences of the human immunodeficiency virus in infants born to sero-positive mothers. N Engl J Med 1989;320:1649-54.
6. Palumbo PE, Kwok S, Waters S, et al. Viral measurement by polymerase chain reaction-based assays in human immunodeficiency virus-infected infants. J Pediatr 1995;126:592-5.
7. American Academy of Pediatrics, Committee on Pediatric AIDS. Surveillance of pediatric HIV infection. Pediatrics 1998;101:315-9.
8. Nuclisens NASBA Diagnostics HIV-1 RNA QT assay. Package insert. Durham, NC: Organon Teknika Corp., 1996.
9. Steketee RW, Abrams EJ, Thea DM, et al. Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. J Infect Dis 1997;175:707-11.
10. Delamare C, Burgard M, Mayaux MJ, et al. HIV-1 RNA detection in plasma for the diagnosis of infection in neonates. J AIDS 1997;15:121-5.
11. Simonds RJ, Brown TM, Thea DM, et al. Sensitivity and specificity of a qualitative RNA detection assay to diagnose HIV infection in young infants. AIDS 1998;12:1545-9.
12. Souza IE, Azevedo ML, Succi RC, et al. RNA viral load test for early diagnosis of vertical transmission of HIV-1 infection. J AIDS 2000;23:358-60.
13. Cunningham CK, Charbonneau TT, Song K, et al. Comparison of human immunodeficiency virus 1 DNA polymerase chain reaction and qualitative and quantitative RNA polymerase chain reaction in human immunodeficiency virus 1-exposed infants. Pediatr Infect Dis J 1999;18:30-5.
14. Luján-Zilbermann, Bitar W, Flynn P. Validation of a nucleic acid sequence-based amplification HIV-RNA PCR assay (NASBA assay) to determine HIV status of infants born to HIV-positive mothers [Abstract]. In: 102nd General Meeting of the American Society for Microbiology, Salt Lake City, May 19 to 23, 2002.